Evidence map›Paper›PMID 21406101›Full record

Trial reportCritical care (London, England)2011

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

Silvia Fernández-Serrano, Jordi Dorca, Carolina Garcia-Vidal, Núria Fernández-Sabé, Jordi Carratalà, Ana Fernández-Agüera, Mercè Corominas, Susana Padrones, Francesc Gudiol, Frederic Manresa

2 registry-linked trialsOpen access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 70 papers, 22 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 22 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05354778 nacompletednot on this mapstarted 2022, after this paper: background citation

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

TypeinterventionalSponsorInstituto de Assistencia Medica ao Servidor Publico Estadual, Sao PauloRan2022 to 2026Enrolled180ConditionsHealthcare-Associated Pneumonia, Ventilator Associated PneumoniaArmsHydrocortisone, Placebo
NCT07583992 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

TypeinterventionalSponsorNational Research Institute of Chinese Medicine, Ministry of Health and WelfareRan2026 to 2027Enrolled150ConditionsMild to Moderate, Community-Acquired Pneumonia (CAP), Antibiotic Therapy, IntravenousArmsNRICM102, Placebo, Intravenous Antibiotic
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 22 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Corticosteroids for treating sepsis in children and adults.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2020
    Pooled it
  14. Pooled it
  15. Corticosteroids for treating sepsis in children and adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  16. Pooled it
  17. Pooled it
  18. Corticosteroids for pneumonia.The Cochrane database of systematic reviews · 2017
    Pooled it
  19. Pooled it
  20. Pooled it

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Silvia Fernández-SerranoRespiratory Medicine Department, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge, University of Barcelona, Feixa Llarga s/n, L'Hospitalet de Llobregat 08907, Barcelona, Spain.
Jordi Dorca
Carolina Garcia-Vidal
Núria Fernández-Sabé
Jordi Carratalà
Ana Fernández-Agüera
Mercè Corominas
Susana Padrones
Francesc Gudiol
Frederic Manresa
Bellvitge University Hospital · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe benefit of corticosteroids as adjunctive treatment in patients with severe community-acquired pneumonia (CAP) requiring hospital admission remains unclear. This study aimed to evaluate the impact of corticosteroid treatment on outcomes in patients with CAP.

methodsThis was a prospective, double-blind and randomized study. All patients received treatment with ceftriaxone plus levofloxacin and methyl-prednisolone (MPDN) administered randomly and blindly as an initial bolus, followed by a tapering regimen, or placebo.

resultsOf the 56 patients included in the study, 28 (50%) were treated with concomitant corticosteroids. Patients included in the MPDN group show a more favourable evolution of the pO2/FiO2 ratio and faster decrease of fever, as well as greater radiological improvement at seven days. The time to resolution of morbidity was also significantly shorter in this group. Six patients met the criteria for mechanical ventilation (MV): five in the placebo group (22.7%) and one in the MPDN group (4.3%). The duration of MV was 13 days (interquartile range 7 to 26 days) for the placebo group and three days for the only case in the MPDN group. The differences did not reach statistical significance. Interleukin (IL)-6 and C-reactive protein (CRP) showed a significantly quicker decrease after 24 h of treatment among patients treated with MPDN. No differences in mortality were found among groups.

conclusionsMPDN treatment, in combination with antibiotics, improves respiratory failure and accelerates the timing of clinical resolution of severe CAP needing hospital admission.

trial registrationInternational Standard Randomized Controlled Trials Register, ISRCTN22426306.

Indexed as

AgedCommunity-Acquired InfectionsDouble-Blind MethodFemaleFollow-Up StudiesHumansLegionnaires' DiseaseMaleMethylprednisoloneMiddle AgedPneumonia, BacterialProspective StudiesStreptococcal InfectionsTreatment OutcomeMethylprednisolone

Identifiers

PMID21406101
PMCPMC3219361
OpenAlexW2099826587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.